Collectively, these findings strongly suggest that COL6A2 promotes EMT and enhances the proliferative, migratory, and invasive properties of ccRCC cells, largely through the activation of the Wnt/β-catenin signaling pathway. This evidence concerns the gene COL6A2 and nonpapillary renal cell carcinoma.